Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1986-11-19
1990-11-20
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 858, 424 88, 424 93, 43525233, 435848, 435849, A61K 3574, A61K 39108
Patent
active
049717944
ABSTRACT:
Antibodies are produced by hyperimmunizing a mammal, such as cow, with a vaccine derived from E. coli bacteria. The bacterial strains in the vaccine are selected on the basis of their virulence characteristics, especially adhesion factors (pili), associated with gastroenteric disease in humans. The antibodies can be recovered from the mammal's milk or serum, and used in human foods.
REFERENCES:
patent: 3128230 (1964-04-01), Heinboch
patent: 4237115 (1980-12-01), Brinton, Jr.
patent: 4298597 (1981-11-01), Acres et al.
patent: 4343792 (1982-08-01), Gouet et al.
patent: 4411888 (1983-10-01), Klipstein et al.
Gaastra et al., Microbiological Reviews, Jun. 1982, pp. 129-161.
Linggood Margaret A.
Porter Philip
Powell Jonathan R.
Kushan Jeff
Moskowitz Margaret
Unilever Patent Holdings B.V.
LandOfFree
Production of antibodies using a mixture of strains of E. coli c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of antibodies using a mixture of strains of E. coli c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of antibodies using a mixture of strains of E. coli c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-453516